📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies. (2019)

First Author: Picetti R

Attributed to: The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/mbc.0000000000000789

PubMed Identifier: 30585835

Publication URI: http://europepmc.org/abstract/MED/30585835

Type: Journal Article/Review

Volume: 30

Parent Publication: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Issue: 1

ISSN: 0957-5235